Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aysun Komurcu"'
Autor:
Karen Bolhuis, MD, Lodi Grosheide, MD, Nina J. Wesdorp, MD, Aysun Komurcu, MSc, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk J. Grünhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, Joost Huiskens, MD, PhD, Koert P. De Jong, MD, PhD, Geert Kazemier, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Cornelis J. A. Punt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel
Publikováno v:
Annals of Surgery Open, Vol 2, Iss 3, p e081 (2021)
Objective:. To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. Background:. The increase of complex hepatic resections of CRLM, te
Externí odkaz:
https://doaj.org/article/5e754ce85cf045fbad154fecb26942d0
Autor:
Karen Bolhuis, Iris van 't Erve, Clinton Mijnals, Pien M. Delis – Van Diemen, Joost Huiskens, Aysun Komurcu, Marta Lopez-Yurda, Daan van den Broek, Rutger-Jan Swijnenburg, Gerrit A. Meijer, Cornelis J.A. Punt, Remond J.A. Fijneman
Publikováno v:
EBioMedicine, Vol 70, Iss , Pp 103498- (2021)
Background: Recurrence rates after resection of colorectal cancer liver metastases (CRLM) are high and correlate with worse survival. Postoperative circulating tumour DNA (ctDNA) is a promising prognostic biomarker. Focusing on patients with resected
Externí odkaz:
https://doaj.org/article/ac3dfdb0ce244b71940b89028a6d2ade
Autor:
Karen Bolhuis, Marinde J.G. Bond, Martin J. Van Amerongen, Aysun Komurcu, Thiery Chapelle, Cornelis H.C. Dejong, Marc R.W. Engelbrecht, Michael F. Gerhards, Dirk J. Grünhagen, Thomas M. van Gulik, John J. Hermans, Koert P. De Jong, Geert Kazemier, Joost M. Klaase, Niels F.M. Kok, Wouter K.G. Leclercq, Mike S.L. Liem, Krijn P. van Lienden, I. Quintus Molenaar, Ulf P. Neumann, Gijs A. Patijn, Arjen M. Rijken, Theo M. Ruers, Cornelis Verhoef, Johannes H.W. de Wilt, Anne M. May, Cornelis J.A. Punt, Rutger-Jan Swijnenburg
Publikováno v:
European Journal of Cancer, 183, 49-59. Elsevier Limited
European Journal of Cancer, 183, 49-59. Pergamon
Dutch Colorectal Cancer Group Liver Expert Panel 2023, ' The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment : An analysis of the Dutch CAIRO5 trial ', European Journal of Cancer, vol. 183, pp. 49-59 . https://doi.org/10.1016/j.ejca.2023.01.013
European journal of cancer
European Journal of Cancer, 183, pp. 49-59
European Journal of Cancer, 183, 49-59
European Journal of Cancer, 183, 49-59. ELSEVIER SCI LTD
European Journal of Cancer, 183, 49-59. Elsevier Ltd.
European Journal of Cancer, 183, 49-59. Pergamon
Dutch Colorectal Cancer Group Liver Expert Panel 2023, ' The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment : An analysis of the Dutch CAIRO5 trial ', European Journal of Cancer, vol. 183, pp. 49-59 . https://doi.org/10.1016/j.ejca.2023.01.013
European journal of cancer
European Journal of Cancer, 183, pp. 49-59
European Journal of Cancer, 183, 49-59
European Journal of Cancer, 183, 49-59. ELSEVIER SCI LTD
European Journal of Cancer, 183, 49-59. Elsevier Ltd.
Contains fulltext : 291422.pdf (Publisher’s version ) (Open Access) BACKGROUND: Large inter-surgeon variability exists in technical anatomical resectability assessment of colorectal cancer liver-only metastases (CRLM) following induction systemic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43a9b6ac4ea5d58022a1458c9be61d2
https://pure.amc.nl/en/publications/the-role-of-tumour-biological-factors-in-technical-anatomical-resectability-assessment-of-colorectal-liver-metastases-following-induction-systemic-treatment(cba15620-c2fd-4a9d-bd5d-e4442a4cee98).html
https://pure.amc.nl/en/publications/the-role-of-tumour-biological-factors-in-technical-anatomical-resectability-assessment-of-colorectal-liver-metastases-following-induction-systemic-treatment(cba15620-c2fd-4a9d-bd5d-e4442a4cee98).html
Autor:
Marinde Bond, Karen Bolhuis, Martin Van Amerongen, Cornelis Dejong, Marc Engelbrecht, Michael Gerhards, Thomas Van Gulik, Koert De Jong, Geert Kazemier, Joost Klaase, Mike Liem, Krijn Van Lienden, Quintus Molenaar, Arjen Rijken, Cornelis Verhoef, Johannes De Wilt, Aysun Komurcu, Marta Lopez-Yurda, Cornelis Punt, Rutger-Jan Swijnenburg
Publikováno v:
European Journal of Surgical Oncology. 49:e24
Autor:
Clinton Mijnals, Karen Bolhuis, Cornelis J. A. Punt, Pien M. Delis-van Diemen, Rutger-Jan Swijnenburg, Daan van den Broek, J. Huiskens, Remond J.A. Fijneman, Gerrit A. Meijer, Marta Lopez-Yurda, Iris van 't Erve, Aysun Komurcu
Publikováno v:
EBioMedicine, 70:103498. Elsevier BV
EBioMedicine, Vol 70, Iss, Pp 103498-(2021)
EBioMedicine
EBioMedicine, Vol 70, Iss, Pp 103498-(2021)
EBioMedicine
BACKGROUND Recurrence rates after resection of colorectal cancer liver metastases (CRLM) are high and correlate with worse survival. Postoperative circulating tumour DNA (ctDNA) is a promising prognostic biomarker. Focusing on patients with resected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a9ee07669d8b85b17767e5969f7d8c
https://pure.amc.nl/en/publications/postoperative-circulating-tumour-dna-is-associated-with-pathologic-response-and-recurrencefree-survival-after-resection-of-colorectal-cancer-liver-metastases(93a3a8b5-1bb8-48fd-9b1e-e254e6a7877e).html
https://pure.amc.nl/en/publications/postoperative-circulating-tumour-dna-is-associated-with-pathologic-response-and-recurrencefree-survival-after-resection-of-colorectal-cancer-liver-metastases(93a3a8b5-1bb8-48fd-9b1e-e254e6a7877e).html
Autor:
Cornelis J. A. Punt, Marinde J.G. Bond, Karen Bolhuis, Olaf Loosveld, Helgi H. Helgason, Jan Willem de Groot, Mathijs P. Hendriks, Emile D. Kerver, Mike S.L. Liem, Arjen M. Rijken, Cornelis Verhoef, Johannes H.W. de Wilt, Koert P. De Jong, Geert Kazemier, Martinus J. van Amerongen, Marc R.W. Engelbrecht, Joost M. Klaase, Aysun Komurcu, Marta I. Lopez-Yurda, Rutger-Jan Swijnenburg
Publikováno v:
Journal of Clinical Oncology. 40:LBA3506-LBA3506
LBA3506 Background: Patients (pts) with initially unresectable CRLM may qualify for curative-intent local therapy after downsizing by induction systemic therapy. The CAIRO5 study aims to find the optimal induction regimen. We present the results of p